ALBEGA Medical GmbH

ALBEGA Medical is a newly established pharmaceutical company developing novel radiopharmaceuticals in oncology. Our lead compound is Tetrofosmin (TTF) that we are developing in 3 indications: GLIOTECT - a novel diagnostic for brain tumors, GLIOTHER - a novel glioma therapeutics, MYOTECT - a myocard diagnostic as a generic to Myoview (GE Healthcare).